NYMOX PHARMACEUTICAL CORP·4

Nov 6, 5:20 PM ET

LANHAM RANDALL J 4

4 · NYMOX PHARMACEUTICAL CORP · Filed Nov 6, 2018

Insider Transaction Report

Form 4
Period: 2018-10-28
LANHAM RANDALL J
DirectorGeneral Counsel
Transactions
  • Purchase

    Common

    2018-10-28$1.72/sh+2,900$4,988152,900 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT